The Company’s target market will be the following:
Short-term development: supplying CBD isolates to producers as active pharmaceutical ingredients (APIs), food additives and cosmetic markets.
Medium-term development: targeted to consumer markets, to produce end products, such as; CBD oil, CBD tobacco juice (e-juice) for vape, medical treatment and health supplements.
Long-term development: diversify in product line like cannabis relevant compounds (such as THC, CBG) to other precious compounds (such as PTX-paclitaxel, hirudin).
The predecessor of CHROMTEC has already established customers globally. We will start supplying those established customers first while targeting new customers.
The legalization of Cannabis in Canada and the legalization of edible cannabis product in 2019, leads to a booming market demand especially where people can buy CBD related products everywhere, it stimulates and contributes to a new era of industry, and there will be more than just a new market, it will be a new economic indicator.
As cannabis industry is a young and booming industry, it is a future trend not only in Canada, but all around the world. Calculated based on the current and potential product application, along with the consumer market size, we are expecting a rough demand of 2,500 tons, globally for CBD (and relevant products). Our products can address demand in this marketplace, proving that we have the industrialized production capacity, tested high purity, and minimized production costs.
